Rhythm Pharmaceuticals Announces Health Canada Approval Of IMCIVREE(R) (setmelanotide) For Weight Management In Adult And Pediatric Patients 4 Years Of Age And Older With Acquired Hypothalamic Obesity >RYTM

Dow Jones2026/09/22 12:00

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

SUI crypto hits 6B transaction blocks, but rising funding flashes a warning

AMBCrypto•2026/09/30 21:33

Crypto advocacy group announces picks for US Congress as midterms loom

Cointelegraph•2026/09/30 19:12

Sui trades at $1.15 after rebound, analysts target $1.27 resistance

Cointurk•2026/09/30 18:30

Miata drills 3.4 g gold at Sela Creek in Suriname

Mining.com•2026/09/30 17:21